Financhill
Sell
48

VTRS Quote, Financials, Valuation and Earnings

Last price:
$9.1400
Seasonality move :
0.27%
Day range:
$9.0300 - $9.1900
52-week range:
$6.8500 - $13.5500
Dividend yield:
5.26%
P/E ratio:
--
P/S ratio:
0.76x
P/B ratio:
0.68x
Volume:
7.1M
Avg. volume:
14.4M
1-year change:
-18.5%
Market cap:
$10.7B
Revenue:
$14.7B
EPS (TTM):
-$3.17

Analysts' Opinion

  • Consensus Rating
    Viatris has received a consensus rating of Hold. The company's average rating is a Hold based on 2 Buy ratings, 6 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $11.3875, Viatris has an estimated upside of 24.86% from its current price of $9.1200.
  • Price Target Downside
    According to analysts, the lowest downside price target is $8.0000 representing 100% downside risk from its current price of $9.1200.

Fair Value

  • According to the consensus of 8 analysts, Viatris has 24.86% upside to fair value with a price target of $11.3875 per share.

VTRS vs. S&P 500

  • Over the past 5 trading days, Viatris has underperformed the S&P 500 by -1.84% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Viatris does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Viatris revenues have been falling on a year-over-year basis for 13 quarters in a row. In the most recent quarter Viatris reported revenues of $3.3B.

Earnings Growth

  • Viatris earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Viatris reported earnings per share of -$2.55.
Enterprise value:
23.9B
EV / Invested capital:
--
Price / LTM sales:
0.76x
EV / EBIT:
47.12x
EV / Revenue:
1.67x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
12.98x
Price / Operating cash flow:
5.92x
Enterprise value / EBITDA:
8.44x
Gross Profit (TTM):
$5.3B
Return On Assets:
-8.72%
Net Income Margin (TTM):
-26.45%
Return On Equity:
-20.24%
Return On Invested Capital:
-10.98%
Operating Margin:
-0.27%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Income Statement
Revenue $15.8B $15.4B $14.3B $3.7B $3.3B
Gross Profit $6.3B $6.4B $5.3B $1.5B $1.2B
Operating Income $1.3B $869.7M $93.6M $286.8M -$8.9M
EBITDA $6.2B $3.4B -$530.8M $1B -$2.3B
Diluted EPS $1.57 -$0.06 -$3.17 $0.09 -$2.55
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Balance Sheet
Current Assets $12.3B $11.7B $9.6B $12.9B $9.6B
Total Assets $59B $53.5B $49.3B $47.3B $38.5B
Current Liabilities $10B $9.6B $6.1B $7.8B $5.7B
Total Liabilities $37.6B $33B $28.4B $27.3B $22.8B
Total Equity $21.4B $20.4B $20.9B $20B $15.7B
Total Debt $24.4B $22B $18.8B $18B $14.2B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Cash Flow Statement
Cash Flow Operations $2.8B $2.5B $2.2B $614.6M $535.5M
Cash From Investing $791.5M -$269.3M $1.9B -$154.3M -$65.1M
Cash From Financing -$3.8B -$1.8B -$4.4B -$425.6M -$467M
Free Cash Flow $2.3B $2B $1.8B $563.8M $459.1M
VTRS
Sector
Market Cap
$10.7B
$34.5M
Price % of 52-Week High
67.31%
49.05%
Dividend Yield
5.26%
0%
Shareholder Yield
14.82%
-1.01%
1-Year Price Total Return
-18.5%
-35.15%
Beta (5-Year)
0.896
0.615
Dividend yield:
5.26%
Annualized payout:
$0.48
Payout ratio:
-15.18%
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $9.2375
200-day SMA
Sell
Level $10.4179
Bollinger Bands (100)
Buy
Level 8.048 - 9.728
Chaikin Money Flow
Sell
Level -7.9M
20-day SMA
Buy
Level $9.0525
Relative Strength Index (RSI14)
Buy
Level 53.9271
ADX Line
Sell
Level 16.1598
Williams %R
Neutral
Level -39.4737
50-day SMA
Buy
Level $8.8326
MACD (12, 26)
Buy
Level 2.0464
25-day Aroon Oscillator
Buy
Level 84
On Balance Volume
Neutral
Level 4M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (0.9628)
Sell
CA Score (Annual)
Level (-0.6259)
Buy
Beneish M-Score (Annual)
Level (-2.78)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-1.3427)
Buy
Piotroski F Score (Annual)
Level (5)
Sell
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (5)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Stock Forecast FAQ

In the current month, VTRS has received 2 Buy ratings 6 Hold ratings, and 0 Sell ratings. The VTRS average analyst price target in the past 3 months is $11.3875.

  • Where Will Viatris Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Viatris share price will rise to $11.3875 per share over the next 12 months.

  • What Do Analysts Say About Viatris?

    Analysts are divided on their view about Viatris share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Viatris is a Sell and believe this share price will drop from its current level to $8.0000.

  • What Is Viatris's Price Target?

    The price target for Viatris over the next 1-year time period is forecast to be $11.3875 according to 8 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 6 analysts rate the stock a Hold.

  • Is VTRS A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Viatris is a Hold. 6 of 8 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of VTRS?

    You can purchase shares of Viatris via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Viatris shares.

  • What Is The Viatris Share Price Today?

    Viatris was last trading at $9.1400 per share. This represents the most recent stock quote for Viatris. Yesterday, Viatris closed at $9.1200 per share.

  • How To Buy Viatris Stock Online?

    In order to purchase Viatris stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Roku Stock Undervalued Now?
Is Roku Stock Undervalued Now?

At roughly $89 a share, Roku (NASDAQ: ROKU) trades for barely…

Will Microsoft Be a $5 Trillion Stock?
Will Microsoft Be a $5 Trillion Stock?

Microsoft’s market capitalization sits near $3.73 trillion today. To clear the…

Where Will C3.ai Stock Be in 1 Year?
Where Will C3.ai Stock Be in 1 Year?

C3 .ai (NYSE: AI) has been the poster child for “hype versus execution.”…

Stock Ideas

Buy
69
Is NVDA Stock a Buy?

Market Cap: $4T
P/E Ratio: 56x

Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 43x

Sell
45
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
58
INKT alert for Jul 14

MiNK Therapeutics [INKT] is down 36.03% over the past day.

Buy
51
NEGG alert for Jul 14

Newegg Commerce [NEGG] is down 26.42% over the past day.

Buy
68
ATRO alert for Jul 14

Astronics [ATRO] is down 1.02% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock